Praxis Precision Medicines, Inc.

PRAX

Healthcare · 367.98 +0.1% today

Isolated · not yet confirmedMarket checked 25 Aug, 15:55 GMT-4

Jodie situation report

Praxis Precision Medicines, Inc.'s current read is isolated; its market group is not confirming.

The latest filing evidence is available. 0 of 37 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 0 directly disclosed connections are confirming.

What changed

The operating loss widened by 20.8M.

Company+0.1% todayVolume comparison unavailable

Market group0 of 37 activeBiotechnology · unavailable

Disclosed network0 of 3 confirmingNo filing-linked name is confirming now

What would change this read

Solidus expense rose $9.7 million, including a $5.0 million Ionis milestone and EMBRAVE3 pivotal-trial spending.

Invalidation: The isolated read changes if PRAX's group or a disclosed connection begins moving with it.

Watch this read

Who this business touches

The relationships behind PRAX

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Filing peers

ATAIXENECMPS

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 3 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

PRAX is currently a Follower in the organic co-movement group Biotechnology. This group is discovered from market behaviour rather than assigned from an industry taxonomy. No verified filing-linked names are available yet.